Skip to content

GH Research

US · GHRS #2969 by market cap Listed 2021
17.53 -1.03 -5.55%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 17.53 0.00%
30.6417.5317.532026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on GHRS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -6.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D

How much profit the business keeps from each dollar of sales and capital.

Return on equity -21.0% Better than 16%
Return on invested capital -23.2% Better than 12%
Momentum C

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -38.1% Better than 12%
6-month return -20.8% Better than 26%
12-month return (ex latest month) 28.9% Better than 69%
Distance below 52-week high 44.2% Better than 24%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 34.1x Better than 99%
Debt to assets 0.2% Better than 98%
Interest coverage -1,377.8x Better than 2%
Analyst View A+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 187.1% Better than 94%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -8.22%
1M -8.53%
3M -38.88%
6M -22.23%
YTD +38.03%
1Y +25.30%
3Y +183.66%
5Y -32.08%

Key statistics

Price & volume

Prev close
18.56
Open
18.32
Day range
17.29 - 18.32
Avg price
17.62
Volume
299.46K
Turnover
5.27M
Amplitude
5.55%
52-week range
12.04 - 31.44

Valuation

P/E
-22.19
P/E (TTM)
-18.65
P/B
3.45
EPS
-0.79
Net profit
-54.25M
Net assets
349.01M

Share structure

Market cap
1.20B
Float cap
590.64M
Shares out
68.68M
Float shares
33.69M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-06-25
52-week range 28% of range
12.04 31.44

44.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-2.91M net over the window

Short interest

Shares short
2.08M
As of
2026-10-30

Frequently asked questions

What is the current stock price of GH Research (GHRS)?

GH Research last traded at 17.53. This page shows a periodic quote snapshot. Check the displayed quote time.

What is GH Research's market cap?

About 1.20B.

What is the P/E ratio of GH Research?

The trailing twelve-month P/E is -18.65. The Valuation tab shows it against the stock's own five-year range.

Does GH Research pay a dividend?

GH Research does not currently pay a regular dividend.

Is GH Research a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 50.33, which implies 187.1% upside from the current price. This is not investment advice.

What is GH Research's StockVane Quant Rating?

The StockVane Momentum strategy currently rates GH Research a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

GH Research discussion 0 comments

Add a comment